5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.02▼ | 1.03▼ | 1.03▼ | 1.05▲ | 0.97▲ |
MA10 | 1.06▼ | 1.06▼ | 1.06▼ | 1.03▲ | 0.98▲ |
MA20 | 1.01▲ | 0.99▲ | 0.99▲ | 0.95▲ | 1.00▲ |
MA50 | 1.00▲ | 0.96▲ | 0.96▲ | 0.95▲ | 1.43▼ |
MA100 | 0.98▲ | 1.01▲ | 1.03▼ | 1.01▲ | 11.94▼ |
MA200 | 1.14▼ | 1.28▼ | 1.30▼ | 1.30▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.001▼ | -0.001▼ | 0.013▲ | 0.098▲ |
RSI | 50.955▲ | 51.999▲ | 51.873▲ | 56.545▲ | 42.788▼ |
STOCH | 12.998▼ | 33.654 | 33.654 | 60.074 | 37.267 |
WILL %R | -90.909▼ | -45.454 | -45.454 | -37.838 | -44.643 |
CCI | -70.096 | -26.019 | -26.019 | 44.309 | 137.636▲ |
CDL | $XRTX Engulfing Candlestick Pattern Detected | Set Alert |
Wednesday, April 30, 2025 04:00 AM
XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV ...
|
Monday, April 28, 2025 04:00 AM
Patent Supporting Gout and Autosomal Dominant Polycystic Kidney Disease ProgramsCALGARY, Alberta, April 28, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | ...
|
Sunday, April 27, 2025 09:00 PM
CALGARY, Alberta, April 28, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.02 | 1.06 | 1.015 | 1.05 | 28,564 |
30/04/25 | 1.03 | 1.10 | 1.012 | 1.0202 | 110,128 |
29/04/25 | 1.025 | 1.025 | 1.025 | 1.025 | 40,230 |
28/04/25 | 1.16 | 1.16 | 1.02 | 1.06 | 246,160 |
25/04/25 | 1.05 | 1.19 | 1.04 | 1.08 | 100,982 |
24/04/25 | 1.11 | 1.11 | 1.05 | 1.06 | 49,178 |
23/04/25 | 1.04 | 1.12 | 1.00 | 1.11 | 129,954 |
22/04/25 | 0.90 | 1.13 | 0.90 | 1.05 | 379,354 |
21/04/25 | 0.8873 | 0.948 | 0.87 | 0.87 | 2,358 |
17/04/25 | 0.862 | 0.948 | 0.862 | 0.948 | 9,967 |
|
|
||||
|
|
||||
|
|